HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raymond T Bartus Selected Research

Acids

8/2004A pulmonary formulation of L-dopa enhances its effectiveness in a rat model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raymond T Bartus Research Topics

Disease

19Parkinson Disease (Parkinson's Disease)
01/2020 - 11/2002
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017 - 06/2006
4Alzheimer Disease (Alzheimer's Disease)
01/2017 - 06/2008
4Huntington Disease (Huntington's Disease)
04/2009 - 11/2002
4Neoplasms (Cancer)
07/2002 - 01/2002
3Stroke (Strokes)
09/2009 - 11/2002
2Disease Progression
01/2020 - 04/2009
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2016 - 12/2007
2Weight Loss (Weight Reduction)
10/2011 - 12/2007
2Cerebral Infarction
09/2009 - 04/2008
2Brain Ischemia (Cerebral Ischemia)
09/2009 - 04/2008
2Glioma (Gliomas)
01/2002 - 01/2002
1Sclerosis
01/2017
1Peripheral Nervous System Diseases (PNS Diseases)
01/2017
1Central Nervous System Diseases (CNS Diseases)
11/2012
1Infarction (Infarctions)
09/2009
1Hypertrophy
04/2009
1Cognitive Dysfunction
01/2009
1Ischemic Stroke
04/2008
1Brain Injuries (Brain Injury)
04/2008
1Nervous System Diseases (Neurological Disorders)
06/2006
1Brain Neoplasms (Brain Tumor)
03/2002
1Melanoma (Melanoma, Malignant)
03/2002

Drug/Important Bio-Agent (IBA)

14Nerve Growth Factors (Neurotrophins)IBA
01/2020 - 07/2007
13NeurturinIBA
01/2020 - 01/2007
4Proteins (Proteins, Gene)FDA Link
09/2014 - 06/2006
4Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA
04/2009 - 06/2006
3Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2020 - 04/2009
3Insulin-Like Growth Factor I (IGF-1)IBA
09/2009 - 12/2007
3Pharmaceutical PreparationsIBA
01/2009 - 01/2002
3Carboplatin (JM8)FDA LinkGeneric
07/2002 - 01/2002
2salicylhydroxamic acid (SHAM)IBA
08/2015 - 12/2010
2Nerve Growth Factor (NGF)IBA
09/2014 - 06/2008
2Dopamine (Intropin)FDA LinkGeneric
08/2013 - 08/2004
2Oxidopamine (6 Hydroxydopamine)IBA
10/2011 - 08/2004
1SynucleinsIBA
01/2020
1Melanins (Melanin)IBA
08/2013
1CEREIBA
01/2011
1LectinsIBA
09/2009
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2009
1LigandsIBA
04/2009
1Cholinergic Agents (Cholinergics)IBA
01/2009
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2008
1Insulin (Novolin)FDA Link
04/2008
1Insulin-Like PeptidesIBA
12/2007
13-nitropropionic acidIBA
05/2007
1AcidsIBA
08/2004
1Levodopa (L Dopa)FDA LinkGeneric
08/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2002
1Fluorouracil (Carac)FDA LinkGeneric
07/2002
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2002
1SolutionsIBA
03/2002
1Mannitol (Osmitrol)FDA LinkGeneric
03/2002
1BoronIBA
03/2002
1RMP 7IBA
03/2002
1PolymersIBA
01/2002

Therapy/Procedure

10Therapeutics
01/2020 - 06/2006
3Microspheres (Microsphere)
07/2002 - 01/2002
3Injections
07/2002 - 01/2002
2Drug Therapy (Chemotherapy)
01/2009 - 07/2002
1Denervation
08/2013
1Polypharmacy
07/2002
1Neutron Capture Therapy
03/2002